Abattis Bioceuticals Corp. (OTCPK:ATTB.F) has begun an independent valuation on Green Nature Health Care Products Inc.'s business in order to determine its suitability as a strategic acquisition target. The initial agreement between Green Nature and Abattis gives Abattis the right to acquire Green Nature, by issuing common stock, if the opportunity should be deemed as accretive to Abattis by the board.